Dohn, Line H., et al. “Short Time Infusion of Bevacizumab in Combination With 5FU-Based Chemotherapy As First-Line Therapy in a Non-Selective Patient Group With Metastatic Colorectal Cancer”. Acta Oncologica, vol. 49, no. 3, Jan. 2010, pp. 395-6, doi:10.3109/02841860903428184.